Quince Therapeutics (QNCX)

• Market cap: $55.9M
• 1 day: -4.51%
• 5 days: -7.97%
• 1 month: -12.41%
• 3 months: -32.45%
• 6 months: 63.87%
• Year to date: -32.45%
• 1 year: 16.51%
• 5 years: -97.08%
• 10 years: -96.14%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

24,000% more call options, than puts

Call options by funds: $1.69M | Put options by funds: $7K

136% more capital invested

Capital invested by funds: $4.04M [Q3] → $9.55M (+$5.51M) [Q4]

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

6% more funds holding

Funds holding: 33 [Q3] → 35 (+2) [Q4]

0.39% less ownership

Funds ownership: 12.0% [Q3] → 11.61% (-0.39%) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $4 215% upside
• Avg. target: $7 451% upside
• High target: $10 687% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

D. Boral Capital Jason Kolbert 30% 1-year accuracy 99 / 328 met price target	215% upside $4	Buy Maintained	25 Mar 2025
Oppenheimer Leland Gershell 41% 1-year accuracy 20 / 49 met price target	687% upside $10	Outperform Initiated	24 Mar 2025